![]() ![]() Se comparó la incidencia de MC según sexo, edad, histología y estadio TNM. Para verificar los resultados se usó como criterio la evolución mediante un seguimiento frecuente. Pacientes y métodos: Análisis retrospectivo de los pacientes con CP que tenían un estudio craneal mediante TACC y/o RMC en ausencia de síntomas/signos neurológicos en el momento del diagnóstico. El objetivo del trabajo ha sido evaluar la incidencia de MC silentes en la estadificación inicial del CP mediante tomografía axial computarizada y resonancia magnética craneales (TACC y RMC). Objetivo: Las metástasis cerebrales (MC) son frecuentes en el cáncer de pulmón (CP) y tienen influencia pronóstica y terapéutica. The Journal expresses the voice of the Spanish Respiratory Society of Pulmonology and Thoracic Surgery (SEPAR) as well as that of other scientific societies such as the Latin American Thoracic Society (ALAT) and the Iberian American Association of Thoracic Surgery (AICT).Īuthors are also welcome to submit their articles to the Journal's open access companion title, Open Respiratory Archives. Furthermore, the Journal is also present in Twitter and Facebook. Manuscripts will be submitted electronically using the following web site:, link which is also accessible through the main web page of Archivos de Bronconeumologia.Īccess to any published article, is possible through the Journal's web page as well as from PubMed, Science Direct, and other international databases. The Journal is published monthly in English. It is a monthly Journal that publishes a total of 12 issues and a few supplements, which contain articles belonging to the different sections.Īll the manuscripts received in the Journal are evaluated by the Editors and sent to expert peer-review while handled by the Editor and/or an Associate Editor from the team. Other types of articles such as reviews, editorials, a few special articles of interest to the society and the editorial board, scientific letters, letters to the Editor, and clinical images are also published in the Journal. Gadolinium contrast medium is used in about 1 in 3 of MRI scans to improve the clarity of the images or pictures of your body’s internal structures.Archivos de Bronconeumologia is a scientific journal that preferentially publishes prospective original research articles whose content is based upon results dealing with several aspects of respiratory diseases such as epidemiology, pathophysiology, clinics, surgery, and basic investigation. Why do I need to have gadolinium contrast medium? The contrast medium is injected intravenously (into a vein) as part of an MRI scan, and eliminated from the body through the kidneys. Different brands of gadolinium contrast medium use different chelating molecules. A chelating agent prevents the toxicity of gadolinium while maintaining its contrast properties. The chemical bonds are made between a gadolinium ion and a carrier molecule (a chelating agent). Gadolinium contrast media consist of complex molecules, arrangements of atoms held together by chemical bonds. This allows the radiologist (a specialist doctor trained to examine the images and provide a written report to your doctor or specialist) to more accurately report on how your body is working and whether there is any disease or abnormality present. When injected into the body, gadolinium contrast medium enhances and improves the quality of the MRI images (or pictures). Gadolinium contrast media (sometimes called a MRI contrast media, agents or ‘dyes’) are chemical substances used in magnetic resonance imaging (MRI) scans. Prof Stacy Goergen * What is gadolinium contrast medium? percutaneous transhepatic cholangiogram.18-20 week screening pregnancy ultrasound. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |